Trial Profile
Decitabine administration after allogeneic stem cell transplantation to treat myelodysplastic syndrome and acute myelocytic leukaemia.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Decitabine (Primary) ; Allogeneic stem cell therapy
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 19 Mar 2013 New trial record